19-Nov-2009 - It is “legislative madness” to allow reimportation in the US, according to the chair of EAASM who spoke at AAPS about Europe’s “porous supply chain” and how it could affect the standard of medicines in the States.
19-Nov-2009 - Belgian biotech UCB is to reduce workforce 2 per cent as part of R&D restructuring plan according to various reports.
19-Nov-2009 - in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Xoma and Watson Pharmaceuticals, plus a new role for Fred Hasaan.
18-Nov-2009 - Boehringer Ingelheim looks set for a significant windfall with results from Phase III trials indicating that its drug flibanserin can boost sexual desire in women, raising the prospect of a female equivalent to Pfizer’s Viagra.
17-Nov-2009 - US biotech Emergent BioSolutions has bought a manufacturing facility from Maryland’s MdBio Foundation is a bid to expand its production infrastructure.
17-Nov-2009 - GSK has signed a $540m (€362m) licensing agreement with Nabi Biopharmaceuticals for the Phase III candidate nicotine vaccine, NicVAX.
17-Nov-2009 - Regulatory enforcement efforts to tackle counterfeit and substandard APIs are in disarray, according to Guy Villax, CEO of Hovione, who spoke at AAPS about the scale of the problem.
12-Nov-2009 - AAPS 2009 has drawn to a close but over the three days numerous trends and debates emerged, including the strategies CROs are using in the downturn, and we take a look at these in our conference round up.
10-Nov-2009 - Pfizer will close six R&D facilities in the US and the UK, reducing its global capacity by over a third following completion of its acquisition of Wyeth.
10-Nov-2009 - Following the first full day of AAPS 2009 in Los Angeles, California, US we take a look at the major developments and talking points.
10-Nov-2009 - in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Sanofi-Aventis, RXi Pharmaceuticals and Vivus.
09-Nov-2009 - in-PharmaTechnologist presents an exclusive widget that aggregates all the breaking news from AAPS 2009 in Los Angeles, US, including podcasts, articles and tweets from our in-house journalists at the show.
09-Nov-2009 - The ICH says it made progress on its S9 guideline on non-clinical data requirement for late-stage cancer treatments at its most recent steering committee meeting in Missouri, US.
05-Nov-2009 - US R&D facilities in Rahway and Kenilworth, New Jersey will remain operational as they are vital to the to the newly formed Merck Schering-Plough group, according to CEO Richard Clark.
04-Nov-2009 - GSK and Pfizer have launched their HIV focused JV, ViiV Healthcare with the promise that it will undertake “relentless pursuit” of new drugs.
03-Nov-2009 - Pfizer and Nigerian authorities want Trovan compensation claimants to provide DNA samples to confirm their identity, according to former Nigerian Supreme court justice Abubakar Wali.
03-Nov-2009 - in-PharmaTechnologist presents its latest roundup of movements in the pharma sector, including appointments at Intrexon, Cephalon, NeoPharma and Chelsea Therapeutics.
02-Nov-2009 - Early-stage CDC research suggests that the anti-inflammatory properties of cholesterol-busting statin drugs can help mitigate the impact of flu infection.
02-Nov-2009 - Good news for Human Genome Sciences (HGS) as development partner GSK reports Ph III data showing that their co-owned lupus treatment Benlysta (belimumab) is effective.
29-Oct-2009 - Novavax says its new Indian vaccine plant will be operational in four months with sufficient capacity to help meet local demand for seasonal influenza vaccines.
29-Oct-2009 - Late last week Ecuador’s government announced plans to sidestep patents on more than 2,000 drugs, enabling them to produced local or imported as “generics”
29-Oct-2009 - How successful was the BioPh conference in Madrid? in-PharmaTechnologist asked key players attending the inaugural event.
27-Oct-2009 - in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Hospira, PTI, Migenix and Shrink Nanotechnologies.
22-Oct-2009 - IMS Health has confirmed it is “exploring strategic alternatives” after speculation this week suggested that the market analysis group had received a number of takeover bids.
21-Oct-2009 - The FDA has warned consumers about the spread of counterfeit H1N1 treatments after the agency bought products advertised as Tamiflu (oseltamivir) that contained none of the active ingredient.